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Abstract: Microchimerism refers to the status of harboring cells from another individual at low levels. It is well known that 
cells trafﬁ  c bidirectionally between fetus and mother during pregnancy. This situation resembles a naturally occurring long 
lasting fetal stem cell transplantation. The fetus acts as the donor and the mother acts as the recipient. To study the role of 
microchimerism in tissue regeneration, we constructed a murine microchimerism model with wild type C57BL/6J female 
mice carrying progenies which expressed green ﬂ  uorescent proteins (GFP). Our data indicated that skin injuries in the female 
mice during pregnancy increased microchimerism of GFP expressing cells from the GFP transgenic progenies. The GFP 
positive cells also appeared at the site of spinal cord where injury occurred during pregnancy. Our study suggests that the 
amount of fetal cells in maternal mice signiﬁ  cantly increased if injuries occurred during pregnancy. Fetal stem cells appear 
to respond to maternal injury signals and may play a role in maternal tissue regeneration during pregnancy.
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Introduction
Microchimerism refers to the status of harboring cells from another individual at low levels. It is well 
known that cells trafﬁ  c bidirectionally between fetus and mothers during pregnancy in human (Bianchi 
et al. 1996; Nelson et al. 1998; Maloney et al. 1999; Lo et al. 2000; O’Donoghue et al. 2003; Khosrotehrani 
et al. 2006) and mouse.(Liegeois et al. 1981; Philip et al. 1982) It has been reported that fetal DNA 
presented in women for as long as 27 years following the birth of their last child, and maternal cells 
presented in adult offspring up to 28 years of ages.(Bianchi et al. 1996; Bianchi 1998; Maloney et al. 
1999) The number of fetal cells in maternal circulation between 18 and 22 weeks of pregnancy was 
estimated to be approximately 2–6 cells/ml.(Krabchi et al. 2001) Because the number of fetal cells is 
small (hence called microchimerism), the role of these fetal cells in tissue regeneration has not been 
fully appreciated. Many studies of microchimerism focus on its effects on the host immune system, and 
its role in autoimmune diseases.(Nelson et al. 1998; Nelson 1999; Khosrotehrani et al. 2003; Lambert 
et al. 2003; Adams et al. 2004; Khosrotehrani et al. 2006) Recent studies suggest that these fetal cells 
have stem cell-like properties (Khosrotehrani et al. 2004; Khosrotehrani et al. 2005; Tan et al. 2005).
Using a congenic murine model, we showed here that the fetal cells in the pregnant mice are signif-
icantly increasing at the injury sites if injuries occurred during pregnancy. Our data also indicated that 
fetal cells participated in the repair of skin injury and in spinal cord injury. The fetal cell regenerated 
tissues suggest that the increase of microchimerism is due to the proliferation of fetal cells rather than 
migration of fetal cells. Understanding this repairing mechanism is important in clinical application of 
fetal stem cells for regenerative medicine. The murine injury model reported here provides a platform 
to study the role of fetal stem cells in regeneration of tissues. 
Material and Methods
Animals
Mice were purchased from the Jackson Laboratory (Bar Harbor, ME). Wild type virgin C57Bl/6 female 
mice were bred at the animal facility of the University of Southern California, Los Angeles. To inves-
tigate the fetal-maternal microchimerism, we crossed wild type virgin C57Bl/6 female mice 
(6 to 8-week-old) to congenic male mice (6 to 8   weeks-old) carrying an enhanced green ﬂ  uorescent 
protein (eGFP) gene. The heterozygous transgenic mice (in C57Bl/6 background) carry an enhanced 112
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green ﬂ  uorescent protein (eGFP) gene which is 
under the control of a chicken beta-actin promoter 
and cytomegalovirus enhancer. All the tissues of 
the eGFP transgenic mice, with the exception of 
erythrocytes and hair, are green under excitation 
light. Mice were housed in sterile microisolator 
cages and fed acidiﬁ  ed water and sterilized lab 
chow. All procedures were performed in accor-
dance with the guidelines of the Animal Care and 
Use Committee of the University of Southern 
California.
Injuries
All injuries were introduced under anesthetization 
with ketamine (80 mg/Kg). The skin injuries were 
introduced by shaving the back of the mice and 
dissecting out epidermis and dermis (approxi-
mately 1 cm in diameter). To prevent infection, the 
wounds were covered with sterile plastic wrap. The 
spinal cord injuries were introduced by exposing 
the spine at the T9 vertebral level with dorsal inci-
sion after shaving the skin.
To prevent miscarriage, we introduced only 
minor injury to the spinal cord by punching the 
spine with a 25 gauge needle. The skin wounds 
were close by a wound clip. Two days after the 
delivery of the pups, all maternal mice which 
delivered GFP positive pups were sacriﬁ  ced. The 
skins with skin injuries were dissected out. Spines 
from mice with spinal cord injury were also 
dissected out and the spinal cords containing the 
injury site were ﬂ  ushed out with a syringe.
Results
The experimental design is shown at Figure 1. 
Seven pregnancies were obtained, and all 7 preg-
nancies resulted in the delivery of 5 to 8 pups from 
each pregnancy. After the second week of preg-
nancy, injuries were introduced: skin injuries in 3 
mice; spinal cord injuries in 3 mice; one control 
mouse (which also bred to eGFP males) without 
injury. New skins with scar tissues were formed in 
mice with skin injury without infections approxi-
mately one week post injury. The injured mice lost 
the control of their hind legs for 2 to 3 days. After 
5 days, all mice with spinal cord injury regained 
the control of their hind limbs. Minimal injury is 
introduced here to ensure the successful delivery 
of the pups. All 3 mice with spinal injury delivered 
healthy pups in this study. In all deliveries (from 
all 7 pregnancies), approximately half of the pups 
are GFP positive and are consistent with the auto-
somal dominant inheritance of the hemozugous 
transgenic eGFP gene.
It is known that eGFP is not stable in ﬁ  xed 
sections. Taking advantage of the thin skin of 
mice, we took ﬂ  orescent images of the injured 
area without ﬁ  xation. Massive new blood vessels 
were formed around the injury site which indi-
cated the incidence of high angiogenesis events 
during the recovery of the skin injury (Fig. 2A). 
Under ﬂ  uorescent microscope, eGFP cells were 
observed in the injured sites (Fig. 2B). The eGFP 
cells were distributed in multiple locations and 
formed connected GFP positive tissues. There are 
signiﬁ  cant amounts of eGFP cells (approximately 
30% of the scar tissue based on fluorescent 
microscopy) in the scar tissues, and the cells 
formed integrated GFP positive patches. In 
contrast, the skin next to the injury site showed 
no evidence of angiogenesis and only one isolated 
GFP positive cell was detected (Fig. 2C and 2D). 
This GFP cell may be a migrating fetal cell. The 
GFP positive patches are formed by integrated 
GFP cells, but not a group of single-cells in isola-
tion (Fig. 2B). Skin from control mice showed no 
incident of angiogenesis and no GFP positive cell 
was detected (Fig. 2E). These ﬁ  ndings agree with 
other studies which also found that only a few 
fetal cells were detected in the maternal 
body.(Khosrotehrani et al. 2005; Tan et al. 2005) 
We do not ﬁ  nd signiﬁ  cant amounts of eGFP cells 
in the injured spinal cords (Fig. 2F and 2G). Only 
a few eGFP cells were found in the injured sites 
(Fig. 2G). That result is different from the skin 
injury result, and may be due to the minimal injury 
introduced by the needle, and the size of the 
lesions. The brain, liver and spleen of the mice 
with skin injury were also examined; no eGFP 
positive fetal cells were observed under ﬂ  uores-
cent microscope. The blood from mice with and 
without injuries is also examined. GFP positive 
cells were not identiﬁ  ed with ﬂ  uorescent micros-
copy. 
Discussion
In this study, we examined the role of fetal cells 
in maternal body injuries. Fetal-maternal micro-
chimerism has been reported previously.(Liegeois 
et al. 1981; Philip et al. 1982; Bianchi et al. 1996; 
Artlett et al. 1998; Bianchi 1998; Krabchi et al. 
2001; Khosrotehrani et al. 2003; O’Donoghue 113
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et al. 2003; Khosrotehrani et al. 2004; Aractingi 
et al. 2005; Khosrotehrani et al. 2005; Tan et al. 
2005; Khosrotehrani et al. 2006) Fetal cells were 
found in the maternal body during pregnancy as 
well as postpartum. However, in these studies 
only a small amount of fetal cells were found in 
the maternal body. In our study, we have demon-
strated for the ﬁ  rst time that injury dramatically 
increases the amount of fetal cells in the maternal 
body. The results indicate that injury promoted 
fetal cells migration toward the injury sites and 
proliferation at the sites. In contrast, isolated 
single-cells are detected in areas outside of injury 
sites. These data suggest that there are few 
migrating fetal cells in blood and organs, and the 
integrated GFP positive patches are formed by 
proliferated and differentiated fetal cells.
It has been reported that stem cells actively 
migrate to injury site (Park et al. 2006). We also 
show that fetal cells actively migrate to the 
maternal injury site. The integrated GFP positive 
tissues observed in injuries suggest that they are 
formed by proliferated and differentiated fetal 
cells rather than migrating fetal cells. The 
morphology of these GFP cell patches resemble 
newly formed tissues rather than a group of 
migrating cells. In addition, the accumulation of 
migrating fetal cells is most likely to form a 
continuous GFP positive area rather than separated 
patches of GFP positive areas (Fig. 2 B). Together 
with the fact that fetal cells can be detected in the 
maternal body long after deliveries, these fetal-
maternal chimeric cells are likely stem cells. 
(Bianchi et al. 1996; Khosrotehrani et al. 2005).
GFP Male 
Wild type Female 
skin or spinal injury 
Figure 1. Experimental design for testing the role of injury in microchimerism. Wild type virgin female C57BL/6J mice (8 to 12 weeks old, 
Jackson Laboratory, ME) were crossed with heterozygous transgenic eGFP male mice. Approximately half of the pups carried the eGFP 
genes. This is expected for autosomal dominant inheritance of the eGFP gene.114
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Figure 2. Fetal eGFP cells in injured skin and spinal cord. Both bright ﬁ  eld and ﬂ  uorescent images are taken at 200 × magniﬁ  cation. A. scar 
tissues were formed after skin injury. Massive new blood vessels were visible around the injury site. B. Fluorescent image of the scar tissue 
indicate that patches of fetal eGFP cells are presented close to the blood vessels. C. Fluorescent image of the skin next to the skin injury 
site. There is only one eGFP cells detected (inside the white circle). D. The light microscopic image of C. No angiogenesis signs appeared. 
E. Fluorescent image of skin from the control mouse without injury. There is no GFP positive cells detected. F. The light microscopic image 
of a section of the injured spinal cord. G. Patches of fetal eGFP cells were shown at the scar tissue around the spinal cord.
Our data also agree with previous reports that 
loss of a fetus resulted in higher level of fetal 
microchemirism. (Bianchi et al. 2001; Khosrotehrani 
et al. 2003) The loss of a fetus could be a result 
of injury during pregnancy. Fetal cells have also 
been identiﬁ  ed in skin lesions of women with 
systemic sclerosis, a disease of unknown origin 
which often occurs in women after their child-
bearing years. (Artlett et al. 1998) Different from 
human studies, our study was conducted with 
congenic mice which do not have the issue of 
histocompatibility. This may be the reason that 
only few fetal cells were identiﬁ  ed in women 
with injury during pregnancy (Artlett et al. 
1998).
The fetal-maternal microchimerism is a long 
lasting event during the development of the fetus. 
Our data suggest that the level of microchimerism 
is inﬂ  uenced by whether there is an injury in the 
maternal body. Whether these fetal-maternal cells 
could repair the injury of the mother needs to be 
further investigated by identifying the cell type 115
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of the differentiated fetal cells. However, this 
study suggests that using fetal stem cells for 
regenerative medicine is possible.
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